DoseDenseTherapyMorpheaIn-situCarcinomaWomen ages40+ shouldhave a clinicalbreast examat least yearlyPI3KinaseInhibitorsBreastCancerBOCABrachytherapyGeneMutationAdenocarcinomaEvidencesuggests thatphysical activitymay reduce therisk of breastcancersPathologicResponseLumpectomyGeneticCounselingCytotoxicDefinitiveSurgeryBI-RADSTamoxifenMolecularBreastImagingRelapseDown-StagingHormoneReceptorStatus1 in 8womenSelf-examinationGermlineMutationlatissimusflapBRCAGeneAngiogenesisPrecisionMedicineHormoneReplacementTherapyPalpationER+MetastasisTripleNegativeBreastCancerLymphoscintigraphyMRIMastalgiaEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearRadiotherapyBevacizumabOligometastasesMastectomyTyrosine-KinaseInhibitorCDK4/6InhibitorsFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.ACChemotherapyCo-survivorPagetDiseasePalbociclibCMFChemotherapyCheckpointInhibitorHerceptinAromataseInhibitorsMultimodalityTherapyAntiemeticMastodyniaRaloxifeneECOGScoreNodePositiveBenignPhyllodesTumorKappaEpsilonMultifocalTumorsWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.MegestrolAcetateAntibodyTherapyChemotherapyDiabeticMastopathyLumpNeoadjuvantTherapyCytostaticAnastrozolePARPInhibitorsGailModelLymphNodeStatusHER-2MethotrexateBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55EGFR(epidermalgrowth factorreceptor)ProgestinDimplingInvasiveBreastCancerAdvocacyCystCyclophosphamideIntraductalPapillomaFamilyHistoryTumorGradeCapecitabineAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenOophorectomyAxillarySamplingDocetaxelImmunotherapyAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancermTORInhibitorsMastitisEndometrialCancerRADPaclitaxelCalcificationsKi-67RateAyurvedaSclerosingAdenosisOvarianSuppressionLapatinibFISH5-FluorouracilAdjuvantTherapyTriplePositiveBreastCancerChemopreventionSERMAbsoluteRiskExcisionalBiopsyGeneticPredispositionCAMApoptosisEstradiolDoxorubicinLCISStagingER-BiopsyBilateralProphylacticMastectomyPhyllodesTumorMetastaticBreastCancerAlopeciaGuaranteedRenewableInsuranceNodeNegativeMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltGenomicTestingFibroadenomaBreastTomosynthesisLiquidBiopsyNeoplasmDisease-FreeSurvivalRateEstrogenCachexiaFlowCytometryDoseDenseTherapyMorpheaIn-situCarcinomaWomen ages40+ shouldhave a clinicalbreast examat least yearlyPI3KinaseInhibitorsBreastCancerBOCABrachytherapyGeneMutationAdenocarcinomaEvidencesuggests thatphysical activitymay reduce therisk of breastcancersPathologicResponseLumpectomyGeneticCounselingCytotoxicDefinitiveSurgeryBI-RADSTamoxifenMolecularBreastImagingRelapseDown-StagingHormoneReceptorStatus1 in 8womenSelf-examinationGermlineMutationlatissimusflapBRCAGeneAngiogenesisPrecisionMedicineHormoneReplacementTherapyPalpationER+MetastasisTripleNegativeBreastCancerLymphoscintigraphyMRIMastalgiaEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearRadiotherapyBevacizumabOligometastasesMastectomyTyrosine-KinaseInhibitorCDK4/6InhibitorsFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.ACChemotherapyCo-survivorPagetDiseasePalbociclibCMFChemotherapyCheckpointInhibitorHerceptinAromataseInhibitorsMultimodalityTherapyAntiemeticMastodyniaRaloxifeneECOGScoreNodePositiveBenignPhyllodesTumorKappaEpsilonMultifocalTumorsWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.MegestrolAcetateAntibodyTherapyChemotherapyDiabeticMastopathyLumpNeoadjuvantTherapyCytostaticAnastrozolePARPInhibitorsGailModelLymphNodeStatusHER-2MethotrexateBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55EGFR(epidermalgrowth factorreceptor)ProgestinDimplingInvasiveBreastCancerAdvocacyCystCyclophosphamideIntraductalPapillomaFamilyHistoryTumorGradeCapecitabineAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenOophorectomyAxillarySamplingDocetaxelImmunotherapyAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancermTORInhibitorsMastitisEndometrialCancerRADPaclitaxelCalcificationsKi-67RateAyurvedaSclerosingAdenosisOvarianSuppressionLapatinibFISH5-FluorouracilAdjuvantTherapyTriplePositiveBreastCancerChemopreventionSERMAbsoluteRiskExcisionalBiopsyGeneticPredispositionCAMApoptosisEstradiolDoxorubicinLCISStagingER-BiopsyBilateralProphylacticMastectomyPhyllodesTumorMetastaticBreastCancerAlopeciaGuaranteedRenewableInsuranceNodeNegativeMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltGenomicTestingFibroadenomaBreastTomosynthesisLiquidBiopsyNeoplasmDisease-FreeSurvivalRateEstrogenCachexiaFlowCytometry

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
  1. Dose Dense Therapy
  2. Morphea
  3. In-situ Carcinoma
  4. Women ages 40+ should have a clinical breast exam at least yearly
  5. PI3 Kinase Inhibitors
  6. Breast Cancer
  7. BOCA
  8. Brachytherapy
  9. Gene Mutation
  10. Adenocarcinoma
  11. Evidence suggests that physical activity may reduce the risk of breast cancers
  12. Pathologic Response
  13. Lumpectomy
  14. Genetic Counseling
  15. Cytotoxic
  16. Definitive Surgery
  17. BI-RADS
  18. Tamoxifen
  19. Molecular Breast Imaging
  20. Relapse
  21. Down-Staging
  22. Hormone Receptor Status
  23. 1 in 8 women
  24. Self-examination
  25. Germline Mutation
  26. latissimus flap
  27. BRCA Gene
  28. Angiogenesis
  29. Precision Medicine
  30. Hormone Replacement Therapy
  31. Palpation
  32. ER+
  33. Metastasis
  34. Triple Negative Breast Cancer
  35. Lymphoscintigraphy
  36. MRI
  37. Mastalgia
  38. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  39. Radiotherapy
  40. Bevacizumab
  41. Oligometastases
  42. Mastectomy
  43. Tyrosine-Kinase Inhibitor
  44. CDK4/6 Inhibitors
  45. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  46. AC Chemotherapy
  47. Co-survivor
  48. Paget Disease
  49. Palbociclib
  50. CMF Chemotherapy
  51. Checkpoint Inhibitor
  52. Herceptin
  53. Aromatase Inhibitors
  54. Multimodality Therapy
  55. Antiemetic
  56. Mastodynia
  57. Raloxifene
  58. ECOG Score
  59. Node Positive
  60. Benign Phyllodes Tumor
  61. Kappa Epsilon
  62. Multifocal Tumors
  63. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  64. Megestrol Acetate
  65. Antibody Therapy
  66. Chemotherapy
  67. Diabetic Mastopathy
  68. Lump
  69. Neoadjuvant Therapy
  70. Cytostatic
  71. Anastrozole
  72. PARP Inhibitors
  73. Gail Model
  74. Lymph Node Status
  75. HER-2
  76. Methotrexate
  77. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  78. EGFR (epidermal growth factor receptor)
  79. Progestin
  80. Dimpling
  81. Invasive Breast Cancer
  82. Advocacy
  83. Cyst
  84. Cyclophosphamide
  85. Intraductal Papilloma
  86. Family History
  87. Tumor Grade
  88. Capecitabine
  89. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  90. Oophorectomy
  91. Axillary Sampling
  92. Docetaxel
  93. Immunotherapy
  94. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  95. mTOR Inhibitors
  96. Mastitis
  97. Endometrial Cancer
  98. RAD
  99. Paclitaxel
  100. Calcifications
  101. Ki-67 Rate
  102. Ayurveda
  103. Sclerosing Adenosis
  104. Ovarian Suppression
  105. Lapatinib
  106. FISH
  107. 5-Fluorouracil
  108. Adjuvant Therapy
  109. Triple Positive Breast Cancer
  110. Chemoprevention
  111. SERM
  112. Absolute Risk
  113. Excisional Biopsy
  114. Genetic Predisposition
  115. CAM
  116. Apoptosis
  117. Estradiol
  118. Doxorubicin
  119. LCIS
  120. Staging
  121. ER-
  122. Biopsy
  123. Bilateral Prophylactic Mastectomy
  124. Phyllodes Tumor
  125. Metastatic Breast Cancer
  126. Alopecia
  127. Guaranteed Renewable Insurance
  128. Node Negative
  129. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  130. Genomic Testing
  131. Fibroadenoma
  132. Breast Tomosynthesis
  133. Liquid Biopsy
  134. Neoplasm
  135. Disease-Free Survival Rate
  136. Estrogen
  137. Cachexia
  138. Flow Cytometry